1-7 of 7
Andrew L. Feldman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

Open Access
Brett J Collinge, Laura K Hilton, Jasper Chun Hei Wong, Waleed Alduaij, Susana Ben-Neriah, Graham W. Slack, Pedro Farinha, Merrill Boyle, Barbara Meissner, James R. Cook, German Ott, Andreas Rosenwald, Elías Campo, Catalina Amador, Timothy C Greiner, Philipp W Raess, Joo Y. Song, Giorgio GA Inghirami, Sarah L. Ondrejka, Elaine S Jaffe, Dennis D Weisenburger, Wing C. Chan, Harald Holte, Klaus Beiske, Kai Fu, Jan Delabie, Stefania Pittaluga, Javeed Iqbal, George Wright, Kerry J. Savage, Andrew J Mungall, Louis M Staudt, Christian Steidl, Andrew L. Feldman, Ryan D Morin, Lisa M. Rimsza, David W. Scott
Journal: Blood Advances
Blood Adv bloodadvances.2025016651.
https://doi.org/10.1182/bloodadvances.2025016651
Published: 2025
Includes: Supplemental data
Journal Articles

Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature

Free
Clinical Trials & Observations
Côme Bommier, Brian K. Link, Brianna J. Gysbers, Matthew J. Maurer, Melissa C. Larson, Arushi Khurana, Yucai Wang, Carrie A. Thompson, Dai Chihara, Juan P. Alderuccio, Jean L. Koff, Narendranath Epperla, Annarita Conconi, Izidore S. Lossos, Grzegorz S. Nowakowski, Andrew L. Feldman, Thomas M. Habermann, Rebecca L. King, James R. Cerhan
Journal: Blood Advances
Blood Adv (2024) 8 (23): 5939–5948.
https://doi.org/10.1182/bloodadvances.2024013188
Published: 2024
Includes: Supplemental data
Journal Articles

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Free
Clinical Trials & Observations
Narendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Max J. Gordon, Alexey V. Danilov, Natalie S. Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T. Hill, Nilanjan Ghosh, Steven I. Park, David A. Bond, Mehdi Hamadani, Timothy S. Fenske, Peter Martin, Mary-Kate Malecek, Brad S. Kahl, Christopher R. Flowers, Brian K. Link, Lawrence D. Kaplan, David J. Inwards, Andrew L. Feldman, Eric D. Hsi, Kami Maddocks, Kristie A. Blum, Nancy L. Bartlett, James R. Cerhan, John P. Leonard, Thomas M. Habermann, Matthew J. Maurer, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2287–2296.
https://doi.org/10.1182/bloodadvances.2022009225
Published: 2023
Includes: Supplemental data
Journal Articles

Genetic and immunohistochemical profiling of NK/T-cell lymphomas reveals prognostically relevant BCOR -MYC association

Free
Naoki Oishi, Akira Satou, Masashi Miyaoka, Ichiro Kawashima, Takahiro Segawa, Kunio Miyake, Kunio Mochizuki, Keita Kirito, Andrew L. Feldman, Naoya Nakamura, Tetsuo Kondo
Journal: Blood Advances
Blood Adv (2023) 7 (1): 178–189.
https://doi.org/10.1182/bloodadvances.2022007541
Published: 2023
Includes: Supplemental data
Journal Articles

Increasing tissue requirements in lymphoma trials may exclude patients with high-risk disease or worse prognosis

Free
Clinical Trials & Observations
Sanjal H. Desai, Raphael Mwangi, Wern Lynn Ng, Rebecca L. King, Matthew J. Maurer, James R. Cerhan, Andrew L. Feldman, Umar Farooq, Eric Mou, Thomas M. Habermann, Carrie A. Thompson, Yucai Wang, Thomas E. Witzig, Grzegorz S. Nowakowski
Journal: Blood Advances
Blood Adv (2022) 6 (24): 6180–6186.
https://doi.org/10.1182/bloodadvances.2022007569
Published: 2022
Includes: Supplemental data
Journal Articles

Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study

Free
Aung M. Tun, Arushi Khurana, Raphael Mwangi, Brian K. Link, Yucai Wang, Andrew L. Feldman, Carrie A. Thompson, Anne J. Novak, Jose C. Villasboas, Gita Thanarajasingam, Umar Farooq, Sergei Syrbu, Grzegorz S. Nowakowski, Thomas E. Witzig, Stephen M. Ansell, Lisa M. Rimsza, James R. Cerhan, Thomas M. Habermann, Matthew J. Maurer
Journal: Blood Advances
Blood Adv (2022) 6 (17): 5210–5221.
https://doi.org/10.1182/bloodadvances.2022007990
Published: 2022
Includes: Supplemental data
Journal Articles

Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes

Free
Clinical Trials & Observations
Alessia Castellino, Yucai Wang, Melissa C. Larson, Matthew J. Maurer, Brian K. Link, Umar Farooq, Andrew L. Feldman, Sergei I. Syrbu, Thomas M. Habermann, Jonas Paludo, David J. Inwards, Thomas E. Witzig, Stephen M. Ansell, Cristine Allmer, Susan L. Slager, Jonathon B. Cohen, Peter Martin, James R. Cerhan, Grzegorz S. Nowakowski
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1350–1360.
https://doi.org/10.1182/bloodadvances.2021005715
Published: 2022
Includes: Supplemental data